MMedication Read More A New King of The GLP-1s Could Be Crowned – Cardiac WireOctober 5, 2026 A New King of The GLP-1s Could Be Crowned Cardiac Wire‘Godzilla’ of weight-loss drugs could provide other important health…
MMedication Read More Eli Lilly’s Zepbound plus amylin drug led to major weight loss in mid-stage trialOctober 1, 2026 Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected…
MMedication Read More Doctors condemn Eli Lilly move to dispense GLP-1 medication Mounjaro direct to doorSeptember 30, 2026 A move by a multi-billion-dollar global pharmaceutical company to bypass bricks and mortar pharmacies and deliver its GLP-1…
MMedication Read More Hundreds of lawsuits allege GLP-1s like Ozempic, Wegovy, Mounjaro caused vision lossSeptember 23, 2026 PHOENIX (AZFamily/Gray News) — Hundreds of lawsuits have been filed against major GLP-1 makers Eli Lilly and Novo…
MMedication Read More Hundreds of lawsuits filed against some GLP-1 Makers over vision lossSeptember 22, 2026 Hundreds of Americans are suing GLP-1 drugmakers Novo Nordisk and Ely Lilly, saying they were not adequately warned…
HHealth care Read More Has Novo Nordisk Finally Found the Catalyst That Could Flip the Script on Eli Lilly?August 31, 2026 Novo Nordisk (NYSE: NVO) started the GLP-1 weight-loss revolution that is sweeping the world. Its Wegovy/Ozempic shot was…
HHealth care Read More AbbVie vs. Eli Lilly and: Which Healthcare Stock Is a Better Buy in 2026?August 30, 2026 The pharmaceutical market is currently defined by a race to replace aging blockbusters with next-generation therapies. Deciding whether…
HHealth care Read More Eli Lilly Stock Jumps 2.6% as Investors Flee Expensive TechAugust 19, 2026 This article first appeared on GuruFocus. Eli Lilly (NYSE:LLY), the pharmaceutical powerhouse behind Mounjaro and Zepbound, jumped approximately…
MMedication Read More Eli Lilly CEO still wants deal to bring Mounjaro to Australia under PBSAugust 12, 2026 Eli Lilly pharmaceuticals CEO David Ricks says he still wants to reach an agreement with the Australian government…
MMedication Read More Semaglutide Generics Surge in Sales Despite Supply Challenges, ETPharmaAugust 8, 2026 New Delhi: After a brief slowdown, sales of generic versions of the weight-loss drug semaglutide recorded a strong…
MMedication Read More Will Mounjaro & Zepbound Drive Lilly’s Q2 Results: Buy, Sell or Hold?August 4, 2026 Eli Lilly and Company LLY will report its second-quarter 2026 earnings on Aug. 5, before market open. The Zacks…
MMedication Read More ‘Super weight loss’ drug retatrutide could be available soonJuly 29, 2026 KENT COUNTY, Mich — A new weight loss drug could soon be joining the growing list of medications…